Padmanabh P. Bhatt, Ph.D, has served as our Senior Vice President of Intellectual Property and Chief Scientific Officer since March 2012. Prior to that, he served as our Vice President of Pharmaceutical Sciences beginning in 2005. From 2003 to 2005, Dr. Bhatt was Vice President of Advanced Drug Delivery at Shire Laboratories, Inc. From 2001 to 2003, Dr. Bhatt served as Vice President of Research and Development and Chief Technology Officer at Point Biomedical Corporation. From 1996 to 2001, he served at ALZA (now a Johnson & Johnson company) in various positions, from Product Development Manager to Director of Technical Development. Prior to that time, Dr. Bhatt held positions as Research Specialist and Group Leader of Novel Drug Delivery at Dow Corning Corporation (from 1992 to 1996) and Senior Scientist at Hercon Laboratories (from 1989 to 1992).
Dr. Bhatt earned his B.Pharm and M.Pharm degrees from the University of Bombay, India. He also holds M.S. and Ph.D. degrees in Pharmaceutical Chemistry from the University of Kansas.

Jack A. Khattar is the founder of our company and has served as our President, Chief Executive Officer (CEO), and Director since 2005. From 1999 to 2005, Mr. Khattar served in various positions as a Board member, President, and CEO of Shire Laboratories, Inc., the drug delivery subsidiary of Shire plc. From 1999 to 2004, he also served as a member of Shire plc’s Executive Committee. Prior to that, Khattar served as an Executive Officer and the Chairman of the Management Committee at CIMA Labs Inc., a drug delivery company, where he was also responsible for business development, corporate alliances, and strategic planning. Prior to joining CIMA in 1995, Mr. Khattar held several marketing and business development positions at Merck & Co., Novartis, Playtex, and Kodak in various locations, including the United States, Europe, and the Middle East. Mr. Khattar served on the Board of Rockville Economic Development Inc. from 2003 until 2013. He currently serves on the Board of Directors of Prevacus, Inc., a privately held development stage biotechnology company, and is also Chairman of the Board of scPharmaceuticals, a publicly traded biotechnology company. Mr. Khattar earned his degrees in Marketing with a BBA from American University of Beirut and an MBA from the Wharton School of the University of Pennsylvania.